PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Colestyramine - Post cholecystectomy
PAD Profile : Colestyramine - Post cholecystectomy
Keywords :
Gallbladder removal, undiagnosed diarrhoea
Brand Names Include :
Questran, Questran Light
Traffic Light Status
Status 1 of 2.
Status :
Green
Important
Preferred
Formulations :
- Sachets (powder)
Important Information :
ONLY for those with gastroenterology referral due to undiagnosed diarrhoea post-op.
This is the recommended 1st line treatment option (ordinary sachets, with sugar)
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 2 of 2.
Status :
Green (see narrative)
Important
Formulations :
- Sachets (SUGAR FREE powder)
Important Information :
ONLY for those with gastroenterology referral due to undiagnosed diarrhoea post-op AND are diabetic who request a sugar free formulation. The ordinary powder sachets are 1st line.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Guidelines
No guidelines returned.
Other Drugs
Other Indications
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
01 May 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
The Surrey Heartlands Integrated Care System Area Prescribing Committee agreed the following traffic light statuses and place in therapy for treatments used in post cholecystectomy patients with undiagnosed diarrhoea.
GREEN traffic light status – For patients after cholecystectomy (with undiagnosed diarrhoea) waiting for an appointment with the Gastroenterologist.
· 1st line colestyramine (with sugar)
· 2nd line colesevelam
· 3rd colestyramine (sugar free) – for diabetic patients who request a sugar free formulation. Most costly preparation
Associated BNF Codes
01. Gastro-Intestinal System
01.09.01. Drugs affecting biliary composition and flow